These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15303247)
41. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder. Ketter TA J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635 [TBL] [Abstract][Full Text] [Related]
42. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder. Munizza C; Olivieri L; Di Loreto G; Dionisio P Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574 [TBL] [Abstract][Full Text] [Related]
43. Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Tölle T; Dukes E; Sadosky A Pain Pract; 2006 Sep; 6(3):153-60. PubMed ID: 17147591 [TBL] [Abstract][Full Text] [Related]
44. Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients. Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Schwarz M; Rupprecht R; Romeo E Psychoneuroendocrinology; 2007 Jul; 32(6):669-80. PubMed ID: 17560730 [TBL] [Abstract][Full Text] [Related]
45. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome. de Wet C; Reed L; Glasper A; Moran P; Bearn J; Gossop M Drug Alcohol Depend; 2004 Oct; 76(1):31-5. PubMed ID: 15380286 [TBL] [Abstract][Full Text] [Related]
46. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial. Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711 [TBL] [Abstract][Full Text] [Related]
47. An unusual case of insomnia associated with Whipple encephalopathy: first case reported from Greece. Papadopoulou M; Rentzos M; Vagiakis E; Zouvelou V; Potagas C; Bonakis A; Chatzipanagiotou S; Ioannidis A; Nicolaou C; Vassilopoulos D Neurol Sci; 2005 Jul; 26(3):174-7. PubMed ID: 16086132 [TBL] [Abstract][Full Text] [Related]
48. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. Yegnanarayan R; Mahesh SD; Sangle S Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216 [TBL] [Abstract][Full Text] [Related]
49. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Martinotti G; Di Nicola M; Romanelli R; Andreoli S; Pozzi G; Moroni N; Janiri L Hum Psychopharmacol; 2007 Apr; 22(3):149-56. PubMed ID: 17397097 [TBL] [Abstract][Full Text] [Related]
50. [The use of Lerivon in the therapy of mood disorders]. Iakovlev VA Voen Med Zh; 2000 Jan; 321(1):58-9. PubMed ID: 10701354 [No Abstract] [Full Text] [Related]
51. Effective adjunctive use of low-dose methylphenidate with mianserin for major depression with silent cerebral infarction: a case report. Sekine Y; Iyo M; Tanaka K; Matsuyama K; Matsunaga T; Mori N J Clin Psychopharmacol; 2000 Oct; 20(5):584-5. PubMed ID: 11001248 [No Abstract] [Full Text] [Related]
55. Carbamazepine Treatment of Hyperactivity and Intrusiveness in Dementia. Stewart JT Clin Neuropharmacol; 2018; 41(1):43-44. PubMed ID: 29300206 [TBL] [Abstract][Full Text] [Related]
56. WITHDRAWN: Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Denis C; Fatseas M; Lavie E; Auriacombe M Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD005194. PubMed ID: 23780681 [TBL] [Abstract][Full Text] [Related]
58. Treatment of coprophagia with carbamazepine. Stewart JT Am J Psychiatry; 1995 Feb; 152(2):295. PubMed ID: 7840368 [No Abstract] [Full Text] [Related]